Drug Development

Feliza Mirasol is the science editor for 

Videos

Roquette Pharma Solutions' Christine Mya-San, global account manager, highlights the most significant pharma ingredients at play over the past year and discusses future ingredient innovation.

DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

The value of outsourcing partnerships for next-gen biotherapeutics rests in the expertise and technologies that service providers bring to the table.

Outsourcing Next-Gen Therapies Relies on Expertise and Technology

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.

Axplora Announces €50 Million Investment in GLP-1 Manufacturing in France

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 1

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

Evolving Approaches to Taste Masking 

Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars.

Overcoming Biosimilar Scaling Challenges

CDMOs who have integrated technologies can help further the advancement of ADC development.

Advancing ADCs to the Next Level

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Pharmaceutical Technology chats about the increasing prevalence of challenging APIs in the development pipeline and the hurdles facing formulators and manufacturers as a result of this trend with Jens Schmidt from Lonza.

APIs and Excipients